Results 1 to 10 of about 2,983,446 (436)
Liquid Biopsy in Neurological Diseases [PDF]
Cells, 2023The most recent and non-invasive approach for studying early-stage biomarkers is liquid biopsy. This implies the extraction and analysis of non-solid biological tissues (serum, plasma, saliva, urine, and cerebrospinal fluid) without undergoing invasive ...
S. Malhotra+4 more
semanticscholar +6 more sources
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring [PDF]
Cell Reports Medicine, 2023The emerging field of liquid biopsy stands at the forefront of novel diagnostic strategies for cancer and other diseases. Liquid biopsy allows minimally invasive molecular characterization of cancers for diagnosis, patient stratification to therapy, and ...
S. Batool+47 more
semanticscholar +3 more sources
Liquid biopsy and glioblastoma
Exploration of Targeted Anti-tumor Therapy, 2023Glioblastoma is the most common and malignant primary brain tumor. Despite a century of research efforts, the survival of patients has not significantly improved.
R. Eibl, M. Schneemann
semanticscholar +4 more sources
Liquid Biopsy in Glioblastoma [PDF]
Cancers, 2022Simple Summary Glioblastoma is the most common and malignant primary brain tumor. Despite intensive research for new treatments, the survival of patients has not significantly improved in recent decades.
Lorian Ronvaux+7 more
semanticscholar +6 more sources
Liquid Biopsies in Multiple Myeloma [PDF]
, 2018Multiple myeloma is the second most common hematological malignancy. It is a heterogeneous disease characterized by focal lesions of malignant plasma cells in the bone marrow.
Sedlarikova, Lenka+3 more
core +5 more sources
Biology, 2021
Next-generation sequencing (NGS) has enabled a deeper knowledge of the molecular landscape in non-small cell lung cancer (NSCLC), identifying a growing number of targetable molecular alterations in key genes.
Roberto Serna-Blasco+6 more
doaj +1 more source
Next-generation sequencing (NGS) has enabled a deeper knowledge of the molecular landscape in non-small cell lung cancer (NSCLC), identifying a growing number of targetable molecular alterations in key genes.
Roberto Serna-Blasco+6 more
doaj +1 more source
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
International Journal of Molecular Sciences, 2023Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive approach to determine biomarkers from body fluids, such as blood ...
G. Casagrande+3 more
semanticscholar +1 more source
Exploration of Targeted Anti-tumor Therapy, 2023
Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making.
V. Caputo+5 more
semanticscholar +1 more source
Liquid biopsy is a diagnostic repeatable test, which in last years has emerged as a powerful tool for profiling cancer genomes in real-time with minimal invasiveness and tailoring oncological decision-making.
V. Caputo+5 more
semanticscholar +1 more source
Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway
Journal of Experimental & Clinical Cancer Research, 2022Background Mitochondrial dynamics homeostasis is important for cell metabolism, growth, proliferation, and immune responses. The critical GTPase for mitochondrial fission, Drp1 is frequently upregulated in many cancers and is closely implicated in ...
Yujia Li+14 more
doaj +1 more source
Cancer as an infective disease: the role of EVs in tumorigenesis
Molecular Oncology, 2023Cancer is conventionally considered an evolutionary disease where tumor cells adapt to the environment and evolve eventually leading to the formation of metastasis through the seeding and growth of metastasis‐initiating cells in distant organs.
Lucia Robado de Lope+4 more
doaj +1 more source